Literature DB >> 3258721

Gd-DTPA in MR of spinal lesions.

J Valk1.   

Abstract

The use of Gd-DTPA in nondegenerative spinal lesions is described. Thirty consecutive patients were examined by MR with and without Gd-DTPA. The information obtained with unenhanced T1- and T2-weighted spin-echo images was compared with that obtained with Gd-DTPA T1-weighted images. The results showed that, according to the criteria used, more information was present on the MR images with Gd-DTPA in 18 of 30 patients. In six of 30 patients, the improved quality of the images led to a change in the neurosurgical or neurologic approach. Gd-DTPA proved to be a safe contrast medium; no side effects or adverse reactions were observed. It is recommended that Gd-DTPA be used in nondegenerative lesions involving the spinal cord to obtain the same or more information in a shorter acquisition time.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258721     DOI: 10.2214/ajr.150.5.1163

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  A single focus of probable multiple sclerosis in the cervical spinal cord mimicking a tumour.

Authors:  A Meurice; P Flandroy; R F Dondelinger; M Reznik
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

2.  Spinal cord tumors: gadolinium-DTPA-enhanced MR imaging.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

3.  Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.

Authors:  D Balériaux; C Matos; D De Greef
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.